LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD 72.32 M

LeMaitre Vascular, Inc. EBITDA is USD 72.32 M for the Trailing 12 Months (TTM) ending June 30, 2025, a 28.33% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 56.35 M, a 37.27% change year over year.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 41.05 M, a -8.63% change year over year.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 44.93 M, a -8.84% change year over year.
  • LeMaitre Vascular, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 49.29 M, a 88.45% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)